Folium Bioscience Sees SEC Inquiry Following Failed Australis Merger
Following a failed merger with that of Australis Capital Inc (CSE: AUSA), it appears that an SEC inquiry has begun
Read moreFollowing a failed merger with that of Australis Capital Inc (CSE: AUSA), it appears that an SEC inquiry has begun
Read moreAustralis Capital (CSE: AUSA) has cancelled its previously proposed merger with that of Folium Biosciences as a result of new
Read more